Instructional Course - Requires Course Pass, Additional Registration Required

Instructional Course

059IC - Integrating Molecular Imaging into Urologic Oncology Clinical Practice: Current Approaches & Future Opportunities

Sunday, May 20
4:00 PM - 6:00 PM
Location: MCC WEST, 2002

This course is submitted by the AUA Urologic Diagnostic and Therapeutic Imaging Committee and Laparoscopic, Robotic, and New Surgical Committee. It is intended for urologists interested in optimizing detection, staging, and follow-up of genitourinary malignancies through the use of molecular imaging opportunities. The attendee will explore current diagnostic imaging modalities, their performance characteristics, along with imaging guidelines for initial cancer staging. This will lead into an introduction of novel molecular imaging tests and their clinical applications. Emphasis will be placed on novel PET radiopharmaceutical agents in combination with CT or MRI for prostate (FDG, Choline, Acetate, NaF, FACBC, PSMA), kidney (FDG, Sestamibi, carbonic anhydrase), and urothelial cancers (FDG). Differences among the imaging modalities and how they compare to existing diagnostic tests will be highlighted. Discussions will focus on practical case based examples and integration into clinical practice. At the end of this course, participants should be able to independently determine the strengths and limitations of emerging molecular imaging modalities in urologic oncology.

Learning Objectives:

Send Email for Marc Bjurlin

Michael A. Gorin

Johns Hopkins University School of Medicine

Dr. Michael Gorin is an Assistant Professor of Urology, Oncology, and Radiology at The Johns Hopkins University School of Medicine. He also serves as the Director of Urology Clinical Trials and leads the Program in Image-guided Urology at The James Buchanan Brady Urological Institute. Dr. Gorin is an expert in minimally invasive and image-guided urology. His clinical practice focuses on the care of patients with a range of urologic diseases including prostate cancer, benign prostatic hyperplasia, kidney cancer, and kidney stones. To treat these conditions, Dr. Gorin employs a host of minimally invasive techniques including endoscopy, laparoscopy, robotics, and focal therapy.

Dr. Gorin’s research focuses on the development of novel imaging techniques to address clinical problems within the field of urologic oncology. He has gained considerable notoriety for his work on PSMA-targeted 18F-DCFPyL PET imaging of prostate cancer and 99mTc-sestamibi SPECT/CT imaging of small renal tumors. Dr. Gorin has published over 170 articles in leading medical journals. He is also the recipient of numerous honors and awards including the Drs. Carl and Barbara Alving Endowed Award for Outstanding Biomedical Research, the Urology Care Foundation’s Resident Research Award, and the Frank L. Coulson Jr. Resident Clinical Excellence Award.

Dr. Gorin attended college at the University of Michigan where he earned a Bachelor of Science in Cellular and Molecular Biology. He then went on to attend medical school at the University of Miami Leonard M. Miller School of Medicine where he graduated as an inductee to the Alpha Omega Alpha Honor Medical Society. Following medical school, Dr. Gorin completed a general surgery internship and urology residency at Johns Hopkins University.

Presentation(s):

Send Email for Michael Gorin

Thomas A. Hope

University of California, San Francisco

Thomas Hope, MD, is an Assistant Professor in Residence in the Abdominal Imaging and Nuclear Medicine sections at UCSF and the San Francisco Veterans Affairs Medical Center. In 2007, he received his medical degree from Stanford University School of Medicine and he completed a one-year internship at Kaiser Permanente, San Francisco. From 2008-2012, Dr. Hope completed a residency in Diagnostic Radiology at the University of California, San Francisco, followed by a clinical fellowship in Body MRI and Nuclear Medicine from Stanford Medical Center in 2013. Dr. Hope’s main research focus is on novel imaging agents and therapies. He is the principle investigator on the Ga-68 DOTA-TOC and the Ga-68 PSMA-11 IND at UCSF. He has combined his interest in MR imaging with PET in the simultaneous modality PET/MRI, helping lead the development of the clinical PET/MRI program. Additionally he is developing the PRRT (peptide receptor radionuclide therapy) program for neuroendocrine tumors and prostate cancer at UCSF.

Presentation(s):

Send Email for Thomas Hope

Homer A. Macapinlac

MD Anderson Cancer Center

Dr. Homer A. Macapinlac is the James E. Anderson Distinguished Professor of Nuclear Medicine and Chair of the Department of Nuclear Medicine at the University of Texas M.D. Anderson Cancer Center in Houston, Texas and holds a joint appointment in the Department of Cancer Systems Imaging. Dr. Macapinlac is board certified by the American Board of Nuclear Medicine, with a Certificate of Added Qualification (CAQ) in Nuclear Cardiology. He was also elected as a fellow of the American College of Nuclear Physicians.

Prior to coming to M. D. Anderson, he served as clinical director of the Laurent and Alberta Gershel Positron Emission Tomography Center of Memorial Sloan-Kettering Cancer Center, New York, where he also completed his residency training in Nuclear Medicine and PET fellowship.

Dr. Macapinlac is an active committee member of various groups, and has served as past-Chair of the Institute of Clinical PET. He was past-President of the Society of Nuclear Medicine PET Center of Excellence and received the SNM Distinguished Service Award for this role. Dr. Macapinlac is also an expert consultant to the International Atomic Energy Agency, and an International Visiting Professor for the Radiological Society of North America. He has over 190 publications and is considered a national and international expert in the field of nuclear medicine and positron emission tomography.

Presentation(s):

Send Email for Homer Macapinlac


Assets

059IC - Integrating Molecular Imaging into Urologic Oncology Clinical Practice: Current Approaches & Future Opportunities

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Integrating Molecular Imaging into Urologic Oncology Clinical Practice: Current Approaches & Future Opportunities